Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies
The DOI matches its Crossref record; 147 of the 150 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Dysfunction in the monoamine systems of serotonin (5-HT), norepinephrine (NE) and dopamine (DA) may causally be related to major depressive disorder (MDD). Monoamine depletion studies investigate the direct effects of monoamines on mood. Acute tryptophan depletion (ATD) or para-chlorophenylalanine (PCPA) deplete 5-HT, acute phenylalanine/tyrosine depletion (APTD) or alpha-methyl-para-tyrosine (AMPT) deplete NE/DA. Available depletion studies found conflicting results in heterogeneous populations: healthy controls, patients with previous MDD in remission and patients suffering from MDD. The decrease in mood after 5-HT and NE/DA depletion in humans is reviewed and quantified. Systematic search of MEDLINE and EMBASE (1966-October 2006) and cross-references was carried out. Randomized studies applying ATD, PCPA, APTD or AMPT vs control depletion were included. Pooling of results by meta-analyses was stratified for studied population and design of the study (within or between subjects). Seventy-three ATD, 2 PCPA, 10 APTD and 8 AMPT studies were identified of which 45 ATD and 8 APTD studies could be meta-analyzed. 5-HT or NE/DA depletion did not decrease mood in healthy controls. 5-HT or NE/DA depletion slightly lowered mood in healthy controls with a family history of MDD. In drug-free patients with MDD in remission, a moderate mood decrease was found for ATD, without an effect of APTD. ATD induced relapse in patients with MDD in remission who used serotonergic antidepressants. In conclusion, monoamine depletion studies demonstrate decreased mood in subjects with a family history of MDD and in drug-free patients with MDD in remission, but do not decrease mood in healthy humans. Although depletion studies usefully investigate the etiological link of 5-HT and NE with MDD, they fail to demonstrate a causal relation. They presumably clarify a vulnerability trait to become depressed. Directions for further investigation of this vulnerability trait are proposed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduction of monoamines through acute tryptophan or phenylalanine/tyrosine depletion does not induce depression in healthy subjects (5)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [5]
In the citing paper
“several pieces of evidence have emerged suggesting that the chemical imbalance hypothesis of depression is a drastic oversimplification”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [5]
In the citing paper
“Taking these findings together, it has become increasingly difficult to argue that monoamines have a direct effect on mood, and pharmacological explanations of antidepressant drug action have looked to the downstream neurophysiological effects of the drug to explain their efficacy.”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [7]
In the citing paper
“ATD is much less effective in inducing depressed mood once recovery is established for several months, and it has little effect on mood in healthy people with no familial risk or previous history of depression (Ruhe et al., 2007).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Ruhe et al., 2007
In the citing paper
“ATD in patients recently recovered from depression induces a relapse of symptoms (Delgado et al., 1994;Ruhe et al., 2007).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Ruhe et al., 2007
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Evidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Research works printed but not linked: 6
- American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry 2000; 157: 1–45.
- McNair DM, Lorr M, Droppelman LF . Manual for the Profile of Mood States. Educational and Industrial Testing Service: San Diego, 1988.
- Zuckerman M, Lubin B . Manual for the Multiple Affect Adjective Checklist. Educational and testing service: San Diego, CA, 1965.
- Review Manager [Version 4.2 for Windows]. The Cochrane Collaboration: Oxford, UK, 2002.
- The Cochrane Collaboration. RevMan 4.2 User Guide, Version 4.2 for Windows, 4.2 edn. The Cochrane Collaboration: Oxford, UK, 2002.
- Cochrane Reviewers' Handbook. 4.2.2 [Updated March 2004] edn. John Wiley & Sons, Ltd: Chichester, UK, 2004.
Cited by
Items 201–300 of 914
Doyle, R. E., Hinch, G. N., Fisher, A. D., Boissy, A., Henshall, J. M., & Lee, C. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.018 · Cited by 71
Mertens, L. J., & Preller, K. H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1341-1907 · Cited by 65
Functional polymorphisms in dopamine and serotonin pathway genes
D'Souza, U. M., & Craig, I. W. (2006) · Human Mutation · doi:10.1002/humu.20278 · Cited by 62
Meyer, J. H. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.285 · Cited by 64
Weeks, B. S. (2009) · PubMed · Cited by 85
Molecular mechanisms of psychiatric diseases
Blokhin, I. O., Khorkova, O., Saveanu, R. V., & Wahlestedt, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105136 · Cited by 69
Nonhuman Primate Models in the Genomic Era: A Paradigm Shift
Vallender, E. J., & Miller, G. M. (2013) · ILAR Journal · doi:10.1093/ilar/ilt044 · Cited by 70
Roberts, C., Sahakian, B. J., & Robbins, T. W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.001 · Cited by 65
Presynaptic Receptors for Dopamine, Histamine, and Serotonin
Feuerstein, T. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_10 · Cited by 69
Capitanio, J. P., Kyes, R. C., & Fairbanks, L. A. (2006) · ILAR Journal · doi:10.1093/ilar.47.4.294 · Cited by 62
Schrepf, A., Lutgendorf, S. K., & Pyter, L. M. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.04.010 · Cited by 66
Pringle, A., & Harmer, C. J. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.4/apringle · Cited by 61
Cawley, E., Park, S., aan het Rot, M., Sancton, K., Benkelfat, C., Young, S., Boivin, D., & Leyton, M. (2013) · Journal of Psychiatry & Neuroscience · doi:10.1503/jpn.120181 · Cited by 61
Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance
Costello, H., Roiser, J. P., & Howard, R. (2023) · Psychological Medicine · doi:10.1017/s003329172200397x · Cited by 60
Kirkpatrick, M. G., Goldenson, N. I., Kapadia, N., Kahler, C. W., de Wit, H., Swift, R. M., McGeary, J. E., Sussman, S. Y., & Leventhal, A. M. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4091-y · Cited by 62
Opponent control of reinforcement by striatal dopamine and serotonin
Pinto, D. F. C., Pomrenze, M. B., Guo, M. Y., Touponse, G. C., Chen, A. P. F., Bentzley, B. S., Eshel, N., & Malenka, R. C. (2024) · Nature · doi:10.1038/s41586-024-08412-x · Cited by 63
Developmental imaging genetics: Challenges and promises for translational research
VIDING, E., WILLIAMSON, D. E., & HARIRI, A. R. (2006) · Development and Psychopathology · doi:10.1017/s0954579406060433 · Cited by 57
Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action
Srinivasan, V., Zakaria, R., Othman, Z., Lauterbach, E. C., & Acuña-Castroviejo, D. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11090216 · Cited by 66
Swaab, D. F., & Bao, A. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00023-0 · Cited by 64
Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders
Mocking, R. J. T., Assies, J., Ruhé, H. G., & Schene, A. H. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0158-3 · Cited by 64
Self-citationRetinal electrophysiology in central nervous system disorders. A review of human and mouse studies
Constable, P. A., Lim, J. K. H., & Thompson, D. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1215097 · Cited by 59
Drug withdrawal-induced depression: Serotonergic and plasticity changes in animal models
Renoir, T., Pang, T. Y., & Lanfumey, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.003 · Cited by 57
Recent Advances in the Understanding of Specific Efferent Pathways Emerging From the Cerebellum
Kang, S., Jun, S., Baek, S. J., Park, H., Yamamoto, Y., & Tanaka, K. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.759948 · Cited by 58
The genetics of selective serotonin reuptake inhibitors
Kroeze, Y., Zhou, H., & Homberg, J. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.015 · Cited by 60
Tryptophan supplementation modulates social behavior: A review
Steenbergen, L., Jongkees, B. J., Sellaro, R., & Colzato, L. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.022 · Cited by 63
Pancreatic Cancer–Associated Depression: A Case Report and Review of the Literature
Barnes, A., Yeo, T., Leiby, B., Kay, A., & Winter, J. (2018) · Pancreas · doi:10.1097/mpa.0000000000001148 · Cited by 43
Freimer, N. B., Service, S. K., Ophoff, R. A., Jasinska, A. J., McKee, K., Villeneuve, A., Belisle, A., Bailey, J. N., Breidenthal, S. E., Jorgensen, M. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707640104 · Cited by 54
Mechanisms of antidepressant action: An integrated dopaminergic perspective
Porcelli, S., Drago, A., Fabbri, C., & Serretti, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.005 · Cited by 58
Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity
Wang, M., Ma, Y., Yuan, W., Su, K., & Li, M. D. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9651-3 · Cited by 55
5-HT modulation of pain perception in humans
Martin, S. L., Power, A., Boyle, Y., Anderson, I. M., Silverdale, M., & Jones, A. K. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4686-6 · Cited by 59
The impact of study abroad on improved cultural awareness: a quantitative review
Haas, B. W. (2018) · Intercultural Education · doi:10.1080/14675986.2018.1495319 · Cited by 59
Lemos, J. C., Zhang, G., Walsh, T., Kirby, L. G., Akanwa, A. C., Brooks‐Kayal, A. R., & Beck, S. G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.200 · Cited by 54
The body keeps the score: The neurobiological profile of traumatized adolescents
Laricchiuta, D., Panuccio, A., Picerni, E., Biondo, D., Genovesi, B., & Petrosini, L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105033 · Cited by 55
Doyle, T. A., de Groot, M., Harris, T. B., Schwartz, F., Strotmeyer, E. S., Johnson, K., & Kanaya, A. M. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.08.006 · Cited by 58
5-HT7 receptor signaling: improved therapeutic strategy in gut disorders
Kim, J., & Khan, W. I. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00396 · Cited by 55
Irisin Acts via the PGC-1α and BDNF Pathway to Improve Depression-like Behavior
Jo, D., & Song, J. (2021) · Clinical Nutrition Research · doi:10.7762/cnr.2021.10.4.292 · Cited by 53
Markus, C. R., & Raedt, R. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.221 · Cited by 52
Major depression: emerging therapeutics
Sen, S., & Sanacora, G. (2008) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20043 · Cited by 47
Robinson, O. J., Standing, H. R., DeVito, E. E., Cools, R., & Sahakian, B. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1880-1 · Cited by 47
Perturbation of Serotonin Homeostasis during Adulthood Affects Serotonergic Neuronal Circuitry
Pratelli, M., Migliarini, S., Pelosi, B., Napolitano, F., Usiello, A., & Pasqualetti, M. (2017) · eNeuro · doi:10.1523/eneuro.0376-16.2017 · Cited by 55
Cheng, D., Hong-sheng, C., Ma, S., Guo, J., She, G., Zhang, F., Li, L., Li, X., & Lu, Y. (2018) · Molecules · doi:10.3390/molecules23112832 · Cited by 54
Xu, S., Liu, Y., Pu, J., Gui, S., Zhong, X., Tian, L., Song, X., Qi, X., Wang, H., & Xie, P. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s245282 · Cited by 51
Camilleri, M. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01643.x · Cited by 50
Macoveanu, J., Hornboll, B., Elliott, R., Erritzoe, D., Paulson, O. B., Siebner, H., Knudsen, G. M., & Rowe, J. B. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.264 · Cited by 47
Nutritional interventions in depression and perinatal depression.
Rechenberg, K., & Humphries, D. L. (2013) · PubMed Central · Cited by 64
Gehling, J., Mainka, T., Vollert, J., Pogatzki-Zahn, E. M., Maier, C., & Enax‐Krumova, E. (2016) · BMC Neurology · doi:10.1186/s12883-016-0650-z · Cited by 54
Sorgdrager, F. J. H., Doornbos, B., Penninx, B. W. J. H., de Jonge, P., & Kema, I. P. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.052 · Cited by 51
REVIEW: Non‐human primate models of inheritance vulnerability to alcohol use disorders
Barr, C. S., & Goldman, D. A. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2005.00034.x · Cited by 54
Identifying interactions between genes and early environment in the mouse
Carola, V., Frazzetto, G., & Gross, C. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00152.x · Cited by 50
Ang, B., Horowitz, M. A., & Moncrieff, J. (2022) · SSM - Mental Health · doi:10.1016/j.ssmmh.2022.100098 · Cited by 57
Webhofer, C., Gormanns, P., Tolstikov, V., Zieglgänsberger, W., Sillaber, I., Holsboer, F., & Turck, C. W. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.56 · Cited by 52
Pelosi, B., Migliarini, S., Pacini, G., Pratelli, M., & Pasqualetti, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104318 · Cited by 45
Chimenti, M. S., Fonti, G. L., Conigliaro, P., Triggianese, P., Bianciardi, E., Coviello, M., Lombardozzi, G., Tarantino, G., Niolu, C., Siracusano, A., et al. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-020-00322-2 · Cited by 52
Su, Z., Jia, H., Zhang, H., Feng, Y.-F., An, L., & Zou, Z. (2013) · Molecular BioSystems · doi:10.1039/c3mb70377k · Cited by 53
Camilleri, M. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.261 · Cited by 47
Boot, E., Booij, J., Hasler, G., Zinkstok, J. R., de Haan, L., Linszen, D. H., & van Amelsvoort, T. A. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0739-8 · Cited by 47
Yalçın, İ., Coubard, S., Bodard, S., Chalon, S., & Belzung, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1227-3 · Cited by 47
van Heesch, F., Prins, J., Konsman, J. P., Korte-Bouws, G. A. H., Westphal, K. G. C., Rybka, J., Olivier, B., Kraneveld, A. D., & Korte, S. M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.014 · Cited by 48
Szklany, K., Wopereis, H., de Waard, C., van Wageningen, T., An, R., van Limpt, K., Knol, J., Garssen, J., Knippels, L. M. J., Belzer, C., et al. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1576362 · Cited by 46
Mapping dopaminergic projections in the human brain with resting-state fMRI
Oldehinkel, M., Llera, A., Faber, M., Huertas, I., Buitelaar, J. K., Bloem, B. R., Marquand, A. F., Helmich, R. C. G., Haak, K. V., & Beckmann, C. F. (2022) · eLife · doi:10.7554/elife.71846 · Cited by 51
Wiring and Volume Transmission: An Overview of the Dual Modality for Serotonin Neurotransmission
Gianni, G., & Pasqualetti, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00648 · Cited by 51
Huuhka, K., Anttila, S. A. K., Huuhka, M., Hietala, J. A., Huhtala, H., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.015 · Cited by 47
Feng, Y. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9693-x · Cited by 47
Mechanisms of SSRI Therapy and Discontinuation
Sharp, T., & Collins, H. (2023) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2023_452 · Cited by 55
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants
Niciu, M. J., Mathews, D. C., Nugent, A. C., Ionescu, D. F., Furey, M. L., Richards, E. M., Machado-Vieira, R., & Zarate, C. A. (2014) · Depression and Anxiety · doi:10.1002/da.22224 · Cited by 45
Kriegebaum, C., Song, N.-N., Gutknecht, L., Huang, Y., Schmitt, A., Reif, A., Ding, Y.-Q., & Lesch, K.-P. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.06.015 · Cited by 45
Nonhuman Primate Models of Depression: Effects of Early Experience and Stress
Worlein, J. M. (2014) · ILAR Journal · doi:10.1093/ilar/ilu030 · Cited by 43
Tryptophan Depletion and Emotional Processing in Healthy Volunteers at High Risk for Depression
Feder, A., Skipper, J., Blair, J. R., Buchholz, K., Mathew, S. J., Schwarz, M., Doucette, J. T., Alonso, A., Collins, K. A., Neumeister, A., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.033 · Cited by 44
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate
Graboski, A. L., Kowalewski, M. E., Simpson, J. B., Cao, X., Ha, M., Zhang, J., Walton, W. G., Flaherty, D. P., & Redinbo, M. R. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.07.015 · Cited by 48
Ward, M. P. (2010) · Frontiers in Neuroengineering · doi:10.3389/fneng.2010.00007 · Cited by 43
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
Sharma, S., & Akundi, R. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302120322 · Cited by 46
Ketamine and other glutamate receptor modulators for depression in adults
Amit, B. H., Caddy, C., McCloud, T. L., Rendell, J. M., Hawton, K., Diamond, P. R., McShane, R., & Cipriani, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011612 · Cited by 43
Wang, J., Qiao, J., Zhang, Y., Wang, H., Zhu, S., Zhang, H., Hartle, K., Guo, H., Guo, W., He, J., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12792 · Cited by 43
A Double Dissociation in the Roles of Serotonin and Mood in Healthy Subjects
Robinson, O. J., & Sahakian, B. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.001 · Cited by 43
Correia, A. S., & Vale, N. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4010010 · Cited by 57
Drewes, J. L., Meulendyke, K. A., Liao, Z., Witwer, K. W., Gama, L., Ubaida‐Mohien, C., Li, M., Notarangelo, F. M., Tarwater, P. M., Schwarcz, R. M., et al. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0334-2 · Cited by 43
Lolak, S., Suwannarat, P., & Lipsky, R. H. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800977-2.00005-x · Cited by 46
Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment
Remington, G. J., Agid, O., & Foussias, G. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.191 · Cited by 48
Tributyltin affects shoaling and anxiety behavior in female rare minnow ( Gobiocypris rarus )
Zhang, J., Zhang, C., Sun, P., & Shao, X. (2016) · Aquatic Toxicology · doi:10.1016/j.aquatox.2016.07.007 · Cited by 43
Krishna, G., Beitchman, J. A., Bromberg, C. E., & Thomas, T. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020588 · Cited by 47
Grob, S., Pizzagalli, D. A., Dutra, S. J., Stern, J., Mörgeli, H., Milos, G. F., Schnyder, U., & Hasler, G. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.41 · Cited by 48
Lesch, K., & Mößner, R. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_18 · Cited by 47
Acute hypoglycemia causes depressive-like behaviors in mice
Park, M. J., Yoo, S. W., Choe, B. S., Dantzer, R., & Freund, G. G. (2012) · Metabolism · doi:10.1016/j.metabol.2011.06.013 · Cited by 41
Nucleus accumbens in the pathogenesis of major depressive disorder: A brief review
Yajie, J., Zou, M., Wang, Y., & Wang, Y. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.03.004 · Cited by 43
Presynaptic 5-HT1A is Related to 5-HTT Receptor Density in the Human Brain
Bose, S. K., Mehta, M. A., Selvaraj, S., Howes, O. D., Hinz, R., Rabiner, E. A., Grasby, P. M., Turkheimer, F., & Murthy, N. V. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.113 · Cited by 46
Lee, E.-H., & Han, P.-L. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.014 · Cited by 41
Zhao, J., Jung, Y.-H., Jin, Y., Kang, S., Jang, C., & Lee, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-44052-2 · Cited by 40
Indoleamine 2,3-Dioxygenase Activation and Depressive Symptoms: Results From the Young Finns Study
Elovainio, M., Hurme, M., Jokela, M., Pulkki-Råback, L., Kivimäki, M., Hintsanen, M., Hintsa, T., Lehtimäki, T., Viikari, J., Raitakari, O. T., et al. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318266d0f5 · Cited by 37
Mood state moderates the role of serotonin in cognitive biases
Robinson, O., Cools, R., Crockett, M., & Sahakian, B. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881108100257 · Cited by 38
Howell, B., Godfrey, J., Gutman, D. A., Michopoulos, V., Zhang, X., Nair, G., Hu, X. P., Wilson, M. E., & Sánchez, M. M. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht187 · Cited by 40
Chaudhari, N., & Nampoothiri, L. P. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0035 · Cited by 45
Behavior and Stress Reactivity in Mouse Strains with Mitochondrial DNA Variations
Gimsa, U., Kanitz, E., Otten, W., & Ibrahim, S. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03960.x · Cited by 39
Kabra, A., Garg, R., Brimson, J. M., Živković, J., Almawash, S., Ayaz, M., Nawaz, A., Hassan, S. S. U., & BUNGAU, S. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1046599 · Cited by 41
van Steenbergen, H., Booij, L., Band, G. P. H., Hommel, B., & van der Does, W. A. J. (2012) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-011-0078-2 · Cited by 42
Biney, R. P., Benneh, C. K., Ameyaw, E. O., Boakye‐Gyasi, E., & Woode, E. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.02.023 · Cited by 43
Schneier, F. R., Slifstein, M., Whitton, A. E., Pizzagalli, D. A., Reinen, J., McGrath, P. J., Iosifescu, D. V., & Abi‐Dargham, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.05.014 · Cited by 39
Gui, S., Liu, Y., Zhong, X., Liu, X., Zheng, P., Pu, J., Zhou, J., Chen, J., Zhao, L., Liu, L., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164134 · Cited by 40
Walker, A. J., Burnett, S. A., Hasebe, K., McGillivray, J., Gray, L. J., McGee, S. L., Walder, K. R., Berk, M., & Tye, S. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.033 · Cited by 41
Lower CSF MHPG predicts short-term risk for suicide attempt
Galfalvy, H., Currier, D., Oquendo, M. A., Sullivan, G., Huang, Y.-Y., & John Mann, J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990228 · Cited by 38
Kuhn, M., Weidenauer, A., & Pezawas, L. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139005 · Cited by 45
Metadata
- Authors
- Ruhé, H. G., Mason, N. S., & Schene, A. H.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Ruhé, H G
- Venue
- Molecular Psychiatry
- Published
- 2007-01-16
- Volume
- 12
- Issue
- 4
- Pages
- 331-359
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1990454576
- Cited by
- 861
- References
- 150
- Citations by year
- 2026: 27 · 2025: 26 · 2024: 36 · 2023: 46 · 2022: 43 · 2021: 58 · 2020: 49 · 2019: 44 · 2018: 32 · 2017: 32 · 2016: 40 · 2015: 51 · 2014: 46 · 2013: 55 · 2012: 57
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- monoamine depletion, serotonin, norepinephrine, dopamine, mood, major depressive disorder, tryptophan depletion, alpha-methyl-p-tyrosine, p-chlorophenylalanine, depression vulnerability, relapse, serotonergic antidepressants, family history of depression
- MeSH terms
- Affect, Animals, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Dopamine, Humans, Norepinephrine, Serotonin, Meta-Analysis as Topic, Biogenic Monoamines, Databases, Factual, MEDLINE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.